As drug developers face mounting pressure to accelerate discovery timelines without sacrificing quality, QLNS-CHO offers a compelling solution.

An international study led by MHH compares genomic data from national biobanks worldwide and identifies new risk factors in ...

A research team has developed a technology that distinguishes lung cancer gene mutations solely by measuring the "stiffness" ...

Seven years of investigation by scientists at Harvard Medical School has revealed that the loss of the metal lithium plays a ...

A cure for genetic heart conditions could reach trials in only 5 years, and it “rewrites” DNA. Experts explain the potential ...

Like AI, cells change and learn from experience, while unlike computer chips they arrive naturally preprogrammed ...

In its most basic form, this is the idea of a stem cell. We can say that human cells arise from a process of “differentiation ...

We learn more about the CellCelector, its applications, how it overcomes the limitations of other instruments and top tips ...

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

Reprogrammable RNA nanoparticles activate only in cancer cells to deliver targeted gene-silencing therapy while avoiding ...

An international team of researchers from Germany, Georgia, Armenia, and Norway has analyzed ancient DNA from 230 individuals ...

DGIST research team led by Yoonhee Lee and Gyogwon Koo enhances lung cancer diagnostic accuracy by combining exosome physical ...